Millennium Management’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12.6M Sell
900,501
-592,567
-40% -$8.29M 0.01% 1445
2025
Q1
$20.3M Buy
1,493,068
+1,088,844
+269% +$14.8M 0.01% 1061
2024
Q4
$8.24M Buy
404,224
+344,056
+572% +$7.01M ﹤0.01% 1701
2024
Q3
$1.75M Sell
60,168
-559,761
-90% -$16.3M ﹤0.01% 2633
2024
Q2
$14.4M Buy
619,929
+229,313
+59% +$5.32M 0.01% 1253
2024
Q1
$8.02M Buy
+390,616
New +$8.02M ﹤0.01% 1654
2023
Q4
Sell
-118,351
Closed -$2.44M 4190
2023
Q3
$2.44M Sell
118,351
-359,835
-75% -$7.42M ﹤0.01% 2352
2023
Q2
$14.1M Buy
478,186
+91,897
+24% +$2.71M 0.01% 1217
2023
Q1
$8.9M Buy
386,289
+89,196
+30% +$2.06M 0.01% 1522
2022
Q4
$8.26M Sell
297,093
-199,091
-40% -$5.54M ﹤0.01% 1740
2022
Q3
$15.2M Sell
496,184
-149,152
-23% -$4.58M 0.01% 1141
2022
Q2
$19M Buy
+645,336
New +$19M 0.01% 955
2022
Q1
Sell
-18,360
Closed -$819K 5249
2021
Q4
$819K Sell
18,360
-23,482
-56% -$1.05M ﹤0.01% 3642
2021
Q3
$2.11M Buy
41,842
+22,399
+115% +$1.13M ﹤0.01% 2978
2021
Q2
$1.53M Buy
19,443
+4,731
+32% +$371K ﹤0.01% 3378
2021
Q1
$840K Buy
14,712
+8,898
+153% +$508K ﹤0.01% 3354
2020
Q4
$487K Sell
5,814
-121,874
-95% -$10.2M ﹤0.01% 3255
2020
Q3
$4.58K Buy
127,688
+105,379
+472% +$3.78K 0.01% 1497
2020
Q2
$539K Buy
+22,309
New +$539K ﹤0.01% 2699
2019
Q4
Sell
-101,659
Closed -$1.56M 3534
2019
Q3
$1.56M Buy
+101,659
New +$1.56M ﹤0.01% 2126
2019
Q2
Sell
-34,451
Closed -$800K 3529
2019
Q1
$800K Buy
+34,451
New +$800K ﹤0.01% 2538
2018
Q3
Sell
-171,979
Closed -$2.62M 3547
2018
Q2
$2.62M Buy
+171,979
New +$2.62M ﹤0.01% 1973
2018
Q1
Sell
-94,316
Closed -$1.48M 3458
2017
Q4
$1.48M Buy
+94,316
New +$1.48M ﹤0.01% 2278